901 related articles for article (PubMed ID: 9483160)
21. Projected cost-effectiveness of statewide universal newborn hearing screening.
Keren R; Helfand M; Homer C; McPhillips H; Lieu TA
Pediatrics; 2002 Nov; 110(5):855-64. PubMed ID: 12415021
[TBL] [Abstract][Full Text] [Related]
22. Secondary analysis of economic data: a review of cost-benefit studies of neonatal screening for phenylketonuria.
Lord J; Thomason MJ; Littlejohns P; Chalmers RA; Bain MD; Addison GM; Wilcox AH; Seymour CA
J Epidemiol Community Health; 1999 Mar; 53(3):179-86. PubMed ID: 10396496
[TBL] [Abstract][Full Text] [Related]
23. Inborn Error of Metabolism (IEM) screening in Singapore by electrospray ionization-tandem mass spectrometry (ESI/MS/MS): An 8 year journey from pilot to current program.
Lim JS; Tan ES; John CM; Poh S; Yeo SJ; Ang JS; Adakalaisamy P; Rozalli RA; Hart C; Tan ET; Ranieri E; Rajadurai VS; Cleary MA; Goh DL
Mol Genet Metab; 2014; 113(1-2):53-61. PubMed ID: 25102806
[TBL] [Abstract][Full Text] [Related]
24. [Screening of newborns for inborn errors of metabolism by tandem mass spectrometry].
Simonsen H
Ugeskr Laeger; 2002 Nov; 164(48):5607-12. PubMed ID: 12523003
[TBL] [Abstract][Full Text] [Related]
25. Clinical efficacy and cost-effectiveness of newborn screening for medium chain acyl-CoA dehydrogenase deficiency using tandem mass spectrometry.
Tran K; Banerjee S; Li H; Noorani HZ; Mensinkai S; Dooley K
Clin Biochem; 2007 Feb; 40(3-4):235-41. PubMed ID: 17222812
[TBL] [Abstract][Full Text] [Related]
26. [Neonatal screening in Denmark. Status and future perspectives].
Simonsen H; Brandt NJ; Nørgaard-Pedersen B
Ugeskr Laeger; 1998 Sep; 160(40):5777-82. PubMed ID: 9782755
[TBL] [Abstract][Full Text] [Related]
27. Cost-effectiveness analysis of universal newborn screening for medium chain acyl-CoA dehydrogenase deficiency in France.
Hamers FF; Rumeau-Pichon C
BMC Pediatr; 2012 Jun; 12():60. PubMed ID: 22681855
[TBL] [Abstract][Full Text] [Related]
28. Newborn screening.
Wilcken B; Wiley V
Pathology; 2008 Feb; 40(2):104-15. PubMed ID: 18203033
[TBL] [Abstract][Full Text] [Related]
29. Comprehensive cost-utility analysis of newborn screening strategies.
Carroll AE; Downs SM
Pediatrics; 2006 May; 117(5 Pt 2):S287-95. PubMed ID: 16735255
[TBL] [Abstract][Full Text] [Related]
30. Costing model for neonatal screening and diagnosis of haemoglobinopathies.
Cronin EK; Normand C; Henthorn JS; Hickman M; Davies SC
Arch Dis Child Fetal Neonatal Ed; 1998 Nov; 79(3):F161-7. PubMed ID: 10194984
[TBL] [Abstract][Full Text] [Related]
31. A systematic review of evidence for the appropriateness of neonatal screening programmes for inborn errors of metabolism.
Thomason MJ; Lord J; Bain MD; Chalmers RA; Littlejohns P; Addison GM; Wilcox AH; Seymour CA
J Public Health Med; 1998 Sep; 20(3):331-43. PubMed ID: 9793900
[TBL] [Abstract][Full Text] [Related]
32. Health economic analysis of the neonatal screening program in Japan.
Hisashige A
Int J Technol Assess Health Care; 1994; 10(3):382-91. PubMed ID: 8071001
[TBL] [Abstract][Full Text] [Related]
33. Expanded newborn screening for inborn errors of metabolism by electrospray ionization-tandem mass spectrometry: results, outcome, and implications.
Schulze A; Lindner M; Kohlmüller D; Olgemöller K; Mayatepek E; Hoffmann GF
Pediatrics; 2003 Jun; 111(6 Pt 1):1399-406. PubMed ID: 12777559
[TBL] [Abstract][Full Text] [Related]
34. Inborn errors of metabolism detectable by tandem mass spectrometry in Egypt: The first newborn screening pilot study.
Hassan FA; El-Mougy F; Sharaf SA; Mandour I; Morgan MF; Selim LA; Hassan SA; Salem F; Oraby A; Girgis MY; Mahmoud IG; El-Badawy A; El-Nekhely I; Moharam N; Mehaney DA; Elmonem MA
J Med Screen; 2016 Sep; 23(3):124-9. PubMed ID: 26790708
[TBL] [Abstract][Full Text] [Related]
35. [Tandem mass spectrometry as screening for inborn errors of metabolism].
Campos H D
Rev Med Chil; 2011 Oct; 139(10):1356-64. PubMed ID: 22286738
[TBL] [Abstract][Full Text] [Related]
36. [25 years Austrian screening program for inborn errors of metabolism at the Vienna University].
Widhalm K
Wien Klin Wochenschr; 1992; 104(16):510-3. PubMed ID: 1413809
[TBL] [Abstract][Full Text] [Related]
37. Current practice, accuracy, effectiveness and cost-effectiveness of the school entry hearing screen.
Bamford J; Fortnum H; Bristow K; Smith J; Vamvakas G; Davies L; Taylor R; Watkin P; Fonseca S; Davis A; Hind S
Health Technol Assess; 2007 Aug; 11(32):1-168, iii-iv. PubMed ID: 17683682
[TBL] [Abstract][Full Text] [Related]
38. Economic evaluation of tandem mass spectrometry screening in California.
Feuchtbaum L; Cunningham G
Pediatrics; 2006 May; 117(5 Pt 2):S280-6. PubMed ID: 16735254
[TBL] [Abstract][Full Text] [Related]
39. Diagnosis and therapeutic monitoring of inborn errors of metabolism in 100,077 newborns from Jining city in China.
Yang CJ; Wei N; Li M; Xie K; Li JQ; Huang CG; Xiao YS; Liu WH; Chen XG
BMC Pediatr; 2018 Mar; 18(1):110. PubMed ID: 29534692
[TBL] [Abstract][Full Text] [Related]
40. Telemedicine for the Medicare population: pediatric, obstetric, and clinician-indirect home interventions.
Hersh WR; Wallace JA; Patterson PK; Shapiro SE; Kraemer DF; Eilers GM; Chan BK; Greenlick MR; Helfand M
Evid Rep Technol Assess (Summ); 2001 Aug; (24 Suppl):1-32. PubMed ID: 11569328
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
